Mobile App AIFA Medicinali
Product and provider description
Target populations
Target condition & treatment
Adherence monitoring
Adherence support
Development and evaluation
Product and provider description
Brand name:
AIFA medicinali
AIFA medicinali
Full name:
Mobile App AIFA Medicinali
Mobile App AIFA Medicinali
Brief description:
AIFA (Italian Medicines Agency) has made available an app suitable for mobile devices, developed to provide the citizens with a practical and immediate tool to obtain official information on medicinal products and set reminders to take the medicines, offering the patient or carer support in taking the therapies correctly. This app allows you to directly access the database of medicinal products marketed in Italy, including the Summary of product characteristics and package inserts. You can also be updated on possible shortages of medicines of interest and monitor package deadlines and relevant marketing status.
AIFA (Italian Medicines Agency) has made available an app suitable for mobile devices, developed to provide the citizens with a practical and immediate tool to obtain official information on medicinal products and set reminders to take the medicines, offering the patient or carer support in taking the therapies correctly. This app allows you to directly access the database of medicinal products marketed in Italy, including the Summary of product characteristics and package inserts. You can also be updated on possible shortages of medicines of interest and monitor package deadlines and relevant marketing status.
Technology Readiness Level:
TRL 8: First commercial system
TRL 8: First commercial system
Date first available:
2023-03-22
2023-03-22
Date latest update:
No information available
No information available
Current version identifier:
AIFA medicinali beta
AIFA medicinali beta
Types of components:
Software
Software
Is the technology designed to be used as stand-alone or/and as component of a larger solution:
No information available
No information available
Languages:
Italian
Italian
Countries:
Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Island, Italy, Kosovo, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Moldova, Monaco, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Russia, San Marino, Sweden, Serbia, Slovakia, Slovenia, Spain, Switzerland, Turkey, Ukraine, United Kingdom
Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Island, Italy, Kosovo, Latvia, Lichtenstein, Lithuania, Luxembourg, Malta, Moldova, Monaco, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Russia, San Marino, Sweden, Serbia, Slovakia, Slovenia, Spain, Switzerland, Turkey, Ukraine, United Kingdom
Do any terms and conditions apply?
No information available
No information available
Details terms and conditions:
https://www.aifa.gov.it/mobile-app-aifa
https://www.aifa.gov.it/mobile-app-aifa
Is the technology free of charge or a fee is required for its use?
Free
Free
Provider name:
AIFA (Agenzia Italiana dei Medicinali) – Italian Medicines Agency
AIFA (Agenzia Italiana dei Medicinali) – Italian Medicines Agency
Provider type:
Public or state-owned organisation
Public or state-owned organisation
Provider domain of activity:
Pharmaceutical, Healthcare
Pharmaceutical, Healthcare
Please contact the provider at:
app-medicinali@aifa.gov.it
app-medicinali@aifa.gov.it
Target populations
Is the MATech intended to be used for self-management?
Yes
Yes
Who interacts with the MATech for self-management?
Patient, Caregiver, Other
Patient, Caregiver, Other
Others interacting with the MATech for self-management
Family members
Family members
How many interact:
multiple persons/users (e.g. communication between different users possible via the MATech)
multiple persons/users (e.g. communication between different users possible via the MATech)
Patient age group(s) the MATech is suitable for:
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old
Level of functioning in memory functions the MATech is suitable for:
not specified
not specified
Level of functioning in perception functions the MATech is suitable for:
not specified
not specified
Level of functioning in visual functions the MATech is suitable for:
not specified
not specified
Level of functioning in auditive functions the MATech is suitable for:
not specified
not specified
Level of functioning in movement & mobility the MATech is suitable for:
not specified
not specified
Is the MATech suitable for patients with low literacy (ability to read and write)?
No information available
No information available
Is the MATech suitable for patients with low health literacy (capacity to obtain, process and understand basic health information and services)?
No information available
No information available
Is the MATech suitable for patients with comorbidity?
No information available
No information available
Is the MATech suitable for patients with limited experience with technologies?
No information available
No information available
Is the MATech intended to be used for within an adherence support service?
Yes
Yes
Is the MATech intended to be used by health or social care providers?
No information available
No information available
Is the MATech intended to be used by administrators or health system managers?
No information available
No information available
Target condition & treatment
Target health condition domains for which the MATech is designed:
Generic health relevance
Generic health relevance
The MATech is suitable for medication prescribed:
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
The MATech is suitable for (treatment duration):
No information available
No information available
The MATech is suitable for (administration form):
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
The MATech is suitable for (single/polypharmacy):
Single drug treatments, Polypharmacy (combination therapies)
Single drug treatments, Polypharmacy (combination therapies)
The MATech is suitable for (dosage instructions):
Once-daily doses, Once-per-week doses
Once-daily doses, Once-per-week doses
The MATech is designed to be used for adherence monitoring or intervention:
Intervene to support medication adherence
Intervene to support medication adherence
Brief description:
it allows to manage memo and reminders of used medicines.
it allows to manage memo and reminders of used medicines.
The MATech is designed to be used in (adherence phases):
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Adherence monitoring
Methods used by the MATech to measure adherence:
No information available
No information available
Behavioral aspects targeted by the MATech measurement component:
No information available
No information available
Behaviors targeted by the MATech measurement component:
No information available
No information available
Outcomes targeted by the MATech measurement component:
No information available
No information available
Adherence support
Modes of delivering adherence support used in the technology:
Electronic
Electronic
Printed material formats used:
No information available
No information available
Human interaction formats used:
No information available
No information available
Electronic formats used:
Use of a smartphone or tablet
Use of a smartphone or tablet
Smartphone/tablet formats used:
No information available
No information available
App features included:
includes a reminder system
includes a reminder system
Wearable device formats used:
No information available
No information available
Digital media formats used:
No information available
No information available
Behaviour change content of the intervention (e.g. what adherence barriers and facilitators are targeted, what behaviour change techniques it includes):
App with reminders supporting adherence to medicine use
App with reminders supporting adherence to medicine use
Types of intervention providers involved (i.e. persons using the technology to support patients manage adherence):
Personal care worker, Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Carer, Autonomic device (smart home, robot)
Personal care worker, Family member (Parent or guardian, Spouse or partner, child or grandchild, other), Carer, Autonomic device (smart home, robot)
Types of intervention setting (i.e. where the technology is designed to be used for supporting adherence):
Household residence
Household residence
Telehealth environments applicable:
No information available
No information available
Development and evaluation
Brief description of how the technology has been developed and evaluated (e.g. transparency, theory and evidence base, context compatibility, co-creation, scientific evaluation, etc.):
The Italian Medicine Agency’s initiative stems from a need pointed out by the associations of people with chronic and disabling diseases themselves, who asked for the development of an app to better enable them to check for possible shortages, have agile tools to consult up-to-date information on drugs, receive first indications on ‘What to do when a drug is deficient’, and receive alerts on their availability on the market. https://www.aifa.gov.it/en/-/aifa-lancia-una-app-per-consultare-informazioni-e-ricevere-notifiche-sui-farmaci
The Italian Medicine Agency’s initiative stems from a need pointed out by the associations of people with chronic and disabling diseases themselves, who asked for the development of an app to better enable them to check for possible shortages, have agile tools to consult up-to-date information on drugs, receive first indications on ‘What to do when a drug is deficient’, and receive alerts on their availability on the market. https://www.aifa.gov.it/en/-/aifa-lancia-una-app-per-consultare-informazioni-e-ricevere-notifiche-sui-farmaci
Matech Disclaimer
ENABLE – COST Action CA19132 (ENABLE) maintains this website to enhance public access to our online repository where interested parties would be able to search for medication adherence technologies and learn about them for their research or practice.
Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However, ENABLE accepts no responsibility or liability whatsoever with regard to the information on this site.